A carregar...
Progression-free survival as a surrogate endpoint for overall survival in modern ovarian cancer trials: a meta-analysis
BACKGROUND: Progression-free survival (PFS) has been adopted as the primary endpoint in many randomized controlled trials, and can be determined much earlier than overall survival (OS). We investigated whether PFS is a good surrogate endpoint for OS in trials of first-line treatment for epithelial o...
Na minha lista:
| Publicado no: | Ther Adv Med Oncol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6080081/ https://ncbi.nlm.nih.gov/pubmed/30093922 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835918788500 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|